Bifidobacterium animalis/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on C-reactive protein concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“In this study, hs-CRP levels slightly decreased in the probiotic group (2.94 ± 3.74 to 2.89 ± 3.09 mg/L; Δ = −0.053) and increased in the placebo group (2.94 ± 3.29 to 3.20 ± 3.45 mg/L; Δ = +0.271), with no significant intergroup difference (p = 0.213).”
Quoted verbatim from Bifidobacterium animalis subsp. lactis TISTR 2591 Improves Glycemic Control and Immune Response in Adults with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Crossover Clinical Trial.. - Study
- crossover
- Duration
- 6 weeks
- Dose
- three 350 mg capsules daily (1050 mg), guaranteed minimum 1 x 10^9 CFU/g
- Population
- Thai adults aged 35 to 65 with type 2 diabetes mellitus on metformin monotherapy in both phases; 6-week probiotic and placebo phases with 4-week washout
Bifidobacterium animalis subsp. lactis TISTR 2591 Improves Glycemic Control and Immune Response in Adults with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Crossover Clinical Trial.2025PMID:41097174Permalink
Keep reading
- Everything the graph holds on Bifidobacterium animalis
- Every compound studied against C-reactive protein concentration
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45T10DZFWVSFZFTRHY004E9